BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-136241 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Biologics Contract Manufacturing Demand Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET

7.1 GLOBAL BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING DEMAND MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 BioXcellence (Boehringer Ingelheim GmbH)

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Lonza Group AG

16.3 Samsung Biologics Co. Ltd.

16.4 Fujifilm Diosynth Biotechnologies (FUJIFILM Holdings)

16.5 AbbVie Contract Manufacturing (AbbVie Inc.)

16.6 WuXi Biologics (Cayman) Inc.

16.7 Patheon N.V. (Thermo Fisher Scientific Inc.)

16.8 Emergent BioSolutions Inc.

16.9 AGC Biologics

16.10 Ajinomoto Bio-Pharma (Ajinomoto Co., Inc.)

16.11 Avid Bioservices, Inc.

16.12 KBI Biopharma (JSR Life Sciences (JLS))

16.13 Catalent Inc.

16.14 Abzena Plc

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Product
Monoclonal Antibodies
Vaccines
Growth Factors
Interferons
Recombinant Hormones
Insulin
Others

By Platform
Mammalian
Microbial

By Application
Clinical
Commercial

By Therapeutic Area
Autoimmune Diseases
Oncology
Metabolic Diseases
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Neurology
Respiratory Disorders
Others

Companies

BioXcellence (Boehringer Ingelheim GmbH)
Lonza Group AG
Samsung Biologics Co. Ltd.
Fujifilm Diosynth Biotechnologies (FUJIFILM Holdings)
AbbVie Contract Manufacturing (AbbVie Inc.)
WuXi Biologics (Cayman) Inc.
Patheon N.V. (Thermo Fisher Scientific Inc.)
Emergent BioSolutions Inc.
AGC Biologics
Ajinomoto Bio-Pharma (Ajinomoto Co., Inc.)
Avid Bioservices, Inc.
KBI Biopharma (JSR Life Sciences (JLS))
Catalent Inc.
Abzena Plc

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.